These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 11887456)

  • 1. Treatment of periodontal disease and control of diabetes: an assessment of the evidence and need for future research.
    Grossi SG
    Ann Periodontol; 2001 Dec; 6(1):138-45. PubMed ID: 11887456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Periodontitis and diabetes interrelationships: role of inflammation.
    Iacopino AM
    Ann Periodontol; 2001 Dec; 6(1):125-37. PubMed ID: 11887455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PGE2, IL-1 beta, and TNF-alpha responses in diabetics as modifiers of periodontal disease expression.
    Salvi GE; Beck JD; Offenbacher S
    Ann Periodontol; 1998 Jul; 3(1):40-50. PubMed ID: 9722689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of periodontal disease in diabetics reduces glycated hemoglobin.
    Grossi SG; Skrepcinski FB; DeCaro T; Robertson DC; Ho AW; Dunford RG; Genco RJ
    J Periodontol; 1997 Aug; 68(8):713-9. PubMed ID: 9287060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of antimicrobial periodontal treatment on circulating tumor necrosis factor-alpha and glycated hemoglobin level in patients with type 2 diabetes.
    Iwamoto Y; Nishimura F; Nakagawa M; Sugimoto H; Shikata K; Makino H; Fukuda T; Tsuji T; Iwamoto M; Murayama Y
    J Periodontol; 2001 Jun; 72(6):774-8. PubMed ID: 11453240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Periodontal disease, diabetes, and immune response: a review of current concepts.
    Grant-Theule DA
    J West Soc Periodontol Periodontal Abstr; 1996; 44(3):69-77. PubMed ID: 9477864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of systemic anti-tumor necrosis factor-alpha treatment on Porphyromonas gingivalis infection in type 2 diabetic mice.
    Takano M; Nishihara R; Sugano N; Matsumoto K; Yamada Y; Takane M; Fujisaki Y; Ito K
    Arch Oral Biol; 2010 May; 55(5):379-84. PubMed ID: 20381011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on Actinobacillus Actinomycetemcomitans and Porphyromonas gingivalis in human periodontal disease.
    Slots J
    J Int Acad Periodontol; 1999 Oct; 1(4):121-6. PubMed ID: 12666957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes prevents periodontitis-induced increases in gingival platelet derived growth factor-B and interleukin 1-beta in a rat model.
    Doxey DL; Cutler CW; Iacopino AM
    J Periodontol; 1998 Feb; 69(2):113-9. PubMed ID: 9526909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycated albumin produced in diabetic hyperglycemia promotes monocyte secretion of inflammatory cytokines and bacterial adherence to epithelial cells.
    Shim E; Babu JP
    J Periodontal Res; 2015 Apr; 50(2):197-204. PubMed ID: 24815722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Periodontal inflammation and insulin resistance--lessons from obesity.
    Nishimura F; Murayama Y
    J Dent Res; 2001 Aug; 80(8):1690-4. PubMed ID: 11669476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Porphyromonas gingivalis-induced inflammatory mediator profile in an ex vivo human whole blood model.
    Bodet C; Chandad F; Grenier D
    Clin Exp Immunol; 2006 Jan; 143(1):50-7. PubMed ID: 16367933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blocking proinflammatory cytokine release modulates peripheral blood mononuclear cell response to Porphyromonas gingivalis.
    Berker E; Kantarci A; Hasturk H; Van Dyke TE
    J Periodontol; 2013 Sep; 84(9):1337-45. PubMed ID: 23173823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term responses to periodontal therapy in insulin-dependent diabetic patients.
    Smith GT; Greenbaum CJ; Johnson BD; Persson GR
    J Periodontol; 1996 Aug; 67(8):794-802. PubMed ID: 8866319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble antagonists to interleukin-1 (IL-1) and tumor necrosis factor (TNF) inhibits loss of tissue attachment in experimental periodontitis.
    Delima AJ; Oates T; Assuma R; Schwartz Z; Cochran D; Amar S; Graves DT
    J Clin Periodontol; 2001 Mar; 28(3):233-40. PubMed ID: 11284536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negative effects of chronic inflammatory periodontal disease on diabetes mellitus.
    Nishimura F; Kono T; Fujimoto C; Iwamoto Y; Murayama Y
    J Int Acad Periodontol; 2000 Apr; 2(2):49-55. PubMed ID: 12666961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of IL-6 in the pathogenesis of periodontal disease.
    Irwin CR; Myrillas TT
    Oral Dis; 1998 Mar; 4(1):43-7. PubMed ID: 9655045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Periodontal disease and diabetes mellitus: a two-way relationship.
    Grossi SG; Genco RJ
    Ann Periodontol; 1998 Jul; 3(1):51-61. PubMed ID: 9722690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental periodontitis induced by Porphyromonas gingivalis does not alter the onset or severity of diabetes in mice.
    Li H; Yang H; Ding Y; Aprecio R; Zhang W; Wang Q; Li Y
    J Periodontal Res; 2013 Oct; 48(5):582-90. PubMed ID: 23317150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Animal models for Porphyromonas gingivalis-mediated periodontal disease.
    Genco CA; Van Dyke T; Amar S
    Trends Microbiol; 1998 Nov; 6(11):444-9. PubMed ID: 9846362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.